Skip to main navigation Skip to search Skip to main content

Continuation of Therapeutic Dose Heparin for Critically Ill Patients with COVID-19: REMAP-CAP Randomized Control Trial

  • Charlotte A Bradbury*
  • , Patrick R Lawler
  • , Bryan J McVerry
  • , Ryan Zarychanski
  • *Corresponding author for this work

    Research output: Contribution to journal › Letter (Academic Journal) › peer-review

    7 Citations (Scopus)
    32 Downloads (Pure)
    Original languageEnglish
    Pages (from-to)873-875
    Number of pages3
    JournalIntensive Care Medicine
    Volume49
    DOIs
    Publication statusPublished - 31 May 2023

    Cite this